acetyl-dl-leucine has been researched along with Multiple System Atrophy in 1 studies
acetylleucine: used for treating vestibular-related imbalance and vertigo
Multiple System Atrophy: A syndrome complex composed of three conditions which represent clinical variants of the same disease process: STRIATONIGRAL DEGENERATION; SHY-DRAGER SYNDROME; and the sporadic form of OLIVOPONTOCEREBELLAR ATROPHIES. Clinical features include autonomic, cerebellar, and basal ganglia dysfunction. Pathologic examination reveals atrophy of the basal ganglia, cerebellum, pons, and medulla, with prominent loss of autonomic neurons in the brain stem and spinal cord. (From Adams et al., Principles of Neurology, 6th ed, p1076; Baillieres Clin Neurol 1997 Apr;6(1):187-204; Med Clin North Am 1999 Mar;83(2):381-92)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Scigliuolo, GM | 1 |
| Sagnelli, A | 1 |
| Brenna, G | 1 |
| Pareyson, D | 1 |
| Salsano, E | 1 |
1 trial available for acetyl-dl-leucine and Multiple System Atrophy
| Article | Year |
|---|---|
Lack of benefit of acetyl-dl-leucine in patients with multiple system atrophy of the cerebellar type.
Topics: Adult; Female; Humans; Leucine; Male; Middle Aged; Multiple System Atrophy; Treatment Failure; Young | 2017 |